Under Armour Supports Future Athletes with WIN Global Program

Under Armour  pic
Under Armour
Image: underarmour.com

An accomplished businessman, Anthony W. Deering, has served as Chairman of Exeter Capital, LLC, a private investment firm, since 2004. Alongside his responsibilities with Exeter Capital, Anthony W. Deering is a Director of Under Armour, a leading producer of athletic clothing based in Baltimore. To give back to the communities it serves, Under Armour has undertaken a number of philanthropic initiatives, including WIN Global.

WIN Global aims to empower the next generation of athletes by connecting children in underserved communities to opportunities for playing and practicing sports. To accomplish this mission, WIN Global has undertaken a range of projects, such as improvements to playground areas and the creation of initiatives that teach life skills through sports-driven lessons. In addition, it invests in equipment for participating children and provides support to coaches and other individuals who dedicate their lives to uplifting these communities.

As the name of the program implies, WIN Global seeks to empower communities around the world, and it invites organizations from the communities it serves to apply for grants to further its mission. More information is available online at UnderArmour.com.


Johns Hopkins Medicine Highlights Dangers of Antibiotics

Antibiotics pic
Image: hopkinsmedicine.org

Since 2004, Anthony W. Deering has headed the private investment firm Exeter Capital, LLC, as Chairman. Outside of work, Anthony W. Deering contributes to organizations such as Johns Hopkins Medicine (JHM), where he serves as a Trustee. As one of the nation’s leading health care organizations, JHM undertakes research in a wide range of areas to improve disease prevention and care processes.

Recently, Hopkins researchers looked at nearly 1,500 adult patients who were given antibiotics while in the hospital. The researchers discovered that about a fifth of the cases resulted in undesirable side effects, and about a fifth of those involved patients who did not in fact need antibiotics. More research is emerging about the potential harm of antibiotics, and this new study, published in JAMA Internal Medicine, affirms the findings. Ultimately, researchers want to encourage physicians to consider both risks and benefits before prescribing antibiotics.

The most common side effects of antibiotic use observed in the study included gastrointestinal distress, kidney problems, and blood abnormalities. Patients also experienced new multi-drug-resistant infections and development of a bacterium linked to severe diarrhea. While these side effects did not lead to death in any cases, they led to extended hospital stays, caused hospital readmissions, and necessitated additional diagnostics.